Search
for
Sort by
Research 301–330 of 1000+
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- 711 Small molecule wnt pathway inhibitor (SM04755) as a potential topical psoriasis treatment
- Non-Edg family LPA receptors: the cutting edge of LPA research
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Cthrc1 deficiency aggravates wound healing and promotes cardiac rupture after myocardial infarction via non-canonical WNT5A signaling pathway
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Optimal concentration selection of active pharmaceutical ingredients in the cream-mask intended for androgenic alopecia treatment according to experimental results on paramecium caudatum biological model
- Maternal androgen excess inhibits fetal cardiomyocytes proliferation through RB-mediated cell cycle arrest and induces cardiac hypertrophy in adulthood
- Clinical use of 5α-reductase inhibitors
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Improving selective androgen receptor modulator discovery and preclinical evaluation
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- Physiological and pharmacological features of the non-saponin components in Korean Red Ginseng
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective